|
Lustra (Hydroquinone Cream)
NO prescription required
| |
|
Type |
Strength |
|
Quantity |
|
Price (USD) |
|
|
|
LUSTRA and LUSTRA-AF are indicated for the gradual treatment of ultraviolet induced dyschromia and discoloration resulting from the use of oral contraceptives, pregnancy, hormone replacement therapy, or skin trauma. LUSTRA or LUSTRA-AF should be applied to the affected areas twice daily, morning and before bedtime, or as directed by a physician. During and after the use of LUSTRA sun exposure should be limited, and a sunscreen agent or sun-protective clothing should be used to cover the treated areas, to prevent repigmentation. There is no recommended dosage for pediatric patients under 12 years of age except under the advice and supervision of a physician. LUSTRA and LUSTRA-AF are contraindicated in any patient that has a prior history of hypersensitivity or allergic reaction to hydroquinone or any of the other ingredients. The safety of topical hydroquinone use during pregnancy or on children (12 years and under) has not been established. CAUTION: Hydroquinone is a depigmenting agent which may produce unwanted cosmetic effects if not used as directed. The physician should be familiar with the contents of this insert before prescribing or dispensing this medication. Sunscreen use is an essential aspect of hydroquinone therapy, because even minimal sunlight sustains melanocytic activity. During treatment and maintenance therapy, sun exposure should be avoided on treated skin by application of a broad spectrum sunscreen (SPF 15 or greater) or by use of protective clothing to prevent repigmentation. Although LUSTRA has an antioxidant system in its vehicle, there are no sunblocking or sunscreening agents inLUSTRA. The sunscreens in LUSTRA-AF provide the necessary sun protection during therapy. During and after the use of LUSTRA-AF, sun exposure should be limited or sun-protective clothing should be used to cover the treated areas to prevent repigmentation. WARNING: Contains sodium metabisulfite, a sulfite which may cause serious allergic reactions (e.g., hives, itching, wheezing, anaphylaxis, severe asthma attack) in certain susceptible persons.
|
|
|
|
